We are live on ! Find out more
GCM

Galibier Capital Management Portfolio holdings

AUM $300M
1-Year Est. Return 22.03%
This Fund
S&P 500
This Quarter Est. Return
+1.95%
1 Year Est. Return
+22.03%
3 Year Est. Return
+66.83%
5 Year Est. Return
+107.72%
10 Year Est. Return
AUM
$220M
AUM Growth
+$52.1M
Cap. Flow
+$47.9M
Cap. Flow %
21.82%
Top 10 Hldgs %
77.75%
Holding
34
New
3
Increased
17
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$23.7M
2
EMR icon
Emerson Electric
EMR
+$12.3M
3
MDT icon
Medtronic
MDT
+$10.4M
4
ENB icon
Enbridge
ENB
+$3.59M
5
MFC icon
Manulife Financial
MFC
+$3.05M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$6.89M
2
WBC
WABCO HOLDINGS INC.
WBC
+$1.75M
3
MRK icon
Merck
MRK
+$1.4M
4
OSK icon
Oshkosh
OSK
+$833K
5
MIDD icon
Middleby
MIDD
+$672K

Sector Composition

Rank Sector Weight
1 Financials 33.21%
2 Energy 16.07%
3 Industrials 14.58%
4 Healthcare 14.28%
5 Materials 11.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CM icon
1
Canadian Imperial Bank of Commerce
CM
$107B
$28.4M 12.92%
720,284
+9,234
+1% +$372K
MFC icon
2
Manulife Financial
MFC
$72.6B
$26.8M 12.2%
1,471,864
+171,527
+13% +$3.05M
NTR icon
3
Nutrien
NTR
$32.7B
$24.4M 11.09%
+454,391
New +$23.7M
CVE icon
4
Cenovus Energy
CVE
$54.6B
$21M 9.56%
2,376,994
+115,628
+5% +$1.04M
ENB icon
5
Enbridge
ENB
$124B
$14.3M 6.51%
395,035
+98,501
+33% +$3.59M
EMR icon
6
Emerson Electric
EMR
$82.9B
$13.6M 6.21%
204,372
+184,282
+917% +$12.3M
WBA
7
DELISTED
Walgreens Boots Alliance
WBA
$11.6M 5.3%
212,884
+25,429
+14% +$1.35M
GIB icon
8
CGI
GIB
$13.9B
$11.1M 5.07%
144,682
+2,573
+2% +$187K
MDT icon
9
Medtronic
MDT
$107B
$11.1M 5.07%
+114,304
New +$10.4M
BNS icon
10
Scotiabank
BNS
$106B
$8.4M 3.82%
156,003
+3,202
+2% +$171K
OSK icon
11
Oshkosh
OSK
$9.67B
$5.8M 2.64%
69,520
-10,583
-13% -$833K
HSIC icon
12
Henry Schein
HSIC
$9.74B
$3.81M 1.74%
54,556
SRCL
13
DELISTED
Stericycle Inc
SRCL
$3.51M 1.6%
73,596
STN icon
14
Stantec
STN
$7.69B
$3.47M 1.58%
144,108
MIDD icon
15
Middleby
MIDD
$6.05B
$3.38M 1.54%
24,909
-5,000
-17% -$672K
BUD icon
16
AB InBev
BUD
$158B
$2.44M 1.11%
27,516
+133
+0.5% +$11.4K
RYAAY icon
17
Ryanair
RYAAY
$29.5B
$2.23M 1.01%
86,820
+18,327
+27% +$519K
ING icon
18
ING
ING
$93.8B
$2.17M 0.99%
187,502
+17,924
+11% +$214K
PHG icon
19
Philips
PHG
$25.4B
$2.13M 0.97%
61,553
-1,166
-2% -$37.5K
JPM icon
20
JPMorgan Chase
JPM
$939B
$2.12M 0.96%
18,949
+133
+0.7% +$14.7K
BKNG icon
21
Booking.com
BKNG
$138B
$2.08M 0.95%
27,800
+6,350
+30% +$456K
CTSH icon
22
Cognizant
CTSH
$21.5B
$2.04M 0.93%
32,219
+6,660
+26% +$437K
GOOG icon
23
Alphabet (Google) Class C
GOOG
$3.9T
$2M 0.91%
36,920
+4,340
+13% +$250K
PCOM
24
DELISTED
Points.com Inc. Common Shares
PCOM
$1.91M 0.87%
153,254
AZN icon
25
AstraZeneca
AZN
$263B
$1.89M 0.86%
+22,888
New +$1.79M

Similar funds

Galibier Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Galibier Capital Management held 34 positions worth $220M, up 31% from $168M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Galibier Capital Management deployed $47.9M of net new capital in Q2 2019, opening 3 new positions and adding to 17 existing holdings. Its largest new stake was Nutrien: 454,391 shares worth $24.4M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 40% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Oshkosh, an estimated $833K trimmed.

  • Galibier Capital Management's largest Q2 2019 buy was Nutrien: 454,391 shares worth $24.4M.
  • Galibier Capital Management added most to Emerson Electric in Q2 2019, an estimated $12.3M increase.
  • Galibier Capital Management's biggest Q2 2019 reduction was Oshkosh, cutting an estimated $833K.
  • Galibier Capital Management fully exited Biogen in Q2 2019, selling an estimated $6.89M.
  • Galibier Capital Management's ten largest holdings make up 78% of its $220M portfolio in Q2 2019.
  • Galibier Capital Management opened 3 new positions and closed 3 in Q2 2019.
  • Galibier Capital Management's portfolio value rose 31% quarter-over-quarter to $220M.

Based on Galibier Capital Management's 13F filing for Q2 2019, filed 2 Aug 2019.